Resource Library
Welcome to our resource library, a comprehensive collection of eBooks, white papers, case studies, on-demand webinars, and more.
Four decades of thought leadership, deep academic roots, and strong alliances with industry experts enable us to offer unique insights into every aspect of the drug development cycle.
Explore our full range of resources to enhance your understanding of the therapy-defining power of data analytics and how they can help you make better-informed decisions, no matter where you are on your path to achieving improved patient outcomes.
Webinar – Mastering EU JCA Pass and Local Market Access: Lessons from the First EU JCA Reports
Panel Discussion – One Pivotal Trial Plus Confirmatory Evidence: Understanding FDA’s New Framework
White Paper – The FDA’s Shift to One Pivotal Trial Plus Confirmatory Evidence: A New Era of Evidence for Drug Development
Webinar – FDA CBER Requests in Vaccine Submissions: Lessons from a Recent Submission Preparation
White Paper – Confirmed Best Overall Response (BOR) in Oncology Trials: Why Precise RECIST Programming Matters
Webinar – AI and the Future of Clinical Programming and Biostatistics Roles
Webinar – From Code to Product Knowledge: How AI Is Transforming Clinical Trial Design Workflows
White Paper – Platform Economics: Using R Shiny to Make HEOR Models Interactive, Replicable, and Stakeholder-Centric
Demos & Solutions – Transforming Clinical Trial Design: Advancing Academic Innovation with East Horizon™
Panel Discussion – Closing the Women’s Health Gap Through Better Data & Sex-Sensitive Analyses
Webinar – Rethinking Evidence, Value, and Access: From Artificial Intelligence to Living HTA
Panel Discussion – DMCs Behind Closed Doors: How Recommendations Are Really Made
Claim your free 30-minute strategy session
Book a free, 30-minute strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.